STAT3 and neoplasm: However, our group has recently challenged active IL-6/STAT3 signaling as a tumor driver in PCa, as loss of Stat3 unexpectedly resulted in increased tumor burden and was accompanied by a bypass of PTEN-loss induced cellular senescence (PICS) in a Pten-deficient PCa mouse model [12, 13].